On September 16, 2024, Akanda Corp, a global cannabis company, announced that it has received a license for hemp cultivation in Canada. This license is a result of Akanda’s agreement with 1107385 B.C. LTD and signifies a significant step forward in the company’s strategic endeavors within the Canadian cannabis market.
This milestone underscores Akanda’s dedication to realizing its strategic goals and establishing itself as a prominent player in the global cannabis industry.
Akanda Corp is an international company focused on medical cannabis and wellness solutions, aiming to enhance individuals’ lives through improved access to high-quality and cost-effective products. The company’s portfolio includes CanMart, a UK-based fully licensed pharmaceutical importer and distributor serving pharmacies and clinics in the UK. Additionally, Akanda has partnered with Cellen Life Sciences’ Leva Clinic, a digital pain clinic in the UK, to offer a seed-to-patient supply chain. Furthermore, Akanda has acquired the rights to develop a Canadian farming property in British Columbia for THC and CBD facilities.
It is important to note that certain statements in this press release may constitute forward-looking statements under the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements reflect Akanda’s beliefs about future events, plans, or objectives, which are inherently uncertain and beyond the company’s control. The forward-looking statements are current as of the date of the press release, and Akanda does not commit to updating them unless required by applicable securities laws.
For more information, visit the original press release at the following link: https://www.newsfilecorp.com/release/223482
Source: Akanda Corp
